D.E. Shaw & Co’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-271,291
| Closed | -$46.7M | – | 4410 |
|
|
2021
Q3 | $46.7M | Buy |
271,291
+201,795
| +290% | +$34.7M | 0.04% | 373 |
|
|
2021
Q2 | $8.72M | Sell |
69,496
-3,679
| -5% | -$462K | 0.01% | 1134 |
|
|
2021
Q1 | $9.92M | Buy |
73,175
+11,226
| +18% | +$1.52M | 0.01% | 1007 |
|
|
2020
Q4 | $7.93M | Sell |
61,949
-47,773
| -44% | -$6.11M | 0.01% | 1073 |
|
|
2020
Q3 | $12.3M | Sell |
109,722
-34,964
| -24% | -$3.93M | 0.01% | 804 |
|
|
2020
Q2 | $13.8M | Sell |
144,686
-74,180
| -34% | -$7.07M | 0.02% | 744 |
|
|
2020
Q1 | $19.7M | Buy |
+218,866
| New | +$19.7M | 0.03% | 490 |
|
|
2018
Q4 | – | Sell |
-10,811
| Closed | -$619K | – | 2809 |
|
|
2018
Q3 | $619K | Sell |
10,811
-471
| -4% | -$27K | ﹤0.01% | 2003 |
|
|
2018
Q2 | $547K | Buy |
+11,282
| New | +$547K | ﹤0.01% | 2118 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 2717 |
|
|
2016
Q3 | – | Sell |
-35,205
| Closed | -$1.2M | – | 2720 |
|
|
2016
Q2 | $1.2M | Sell |
35,205
-653
| -2% | -$22.2K | ﹤0.01% | 1705 |
|
|
2016
Q1 | $946K | Sell |
35,858
-4,582
| -11% | -$121K | ﹤0.01% | 1772 |
|
|
2015
Q4 | $1.97M | Buy |
+40,440
| New | +$1.97M | ﹤0.01% | 1412 |
|
|
2015
Q3 | – | Sell |
-29,190
| Closed | -$924K | – | 2773 |
|
|
2015
Q2 | $924K | Buy |
29,190
+10,997
| +60% | +$348K | ﹤0.01% | 1887 |
|
|
2015
Q1 | $692K | Sell |
18,193
-15,586
| -46% | -$593K | ﹤0.01% | 1937 |
|
|
2014
Q4 | $1.32M | Buy |
+33,779
| New | +$1.32M | ﹤0.01% | 1573 |
|
|
2014
Q3 | – | Sell |
-22,352
| Closed | -$759K | – | 2667 |
|
|
2014
Q2 | $759K | Sell |
22,352
-101,449
| -82% | -$3.44M | ﹤0.01% | 1712 |
|
|
2014
Q1 | $4.27M | Buy |
+123,801
| New | +$4.27M | 0.01% | 945 |
|